Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

To bead or not to bead.

Mark E Dudley¹

¹Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. mark_dudley@nih.gov

Journal of Immunotherapy (Hagerstown, Md. : 1997)

|June 14, 2003

Summary

Researchers developed a novel method using magnetic beads to activate tumor-specific T cells. This approach enhances adoptive cell transfer (ACT) therapy for cancer treatment by improving T cell expansion and activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes.

Frontiers in immunology·2023

Same author

Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response.

Journal for immunotherapy of cancer·2017

Same author

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017

Same author

Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2016

Same author

Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2015

Same author

Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2015

Area of Science:

Immunology
Cancer Therapy
Cellular Engineering

Background:

Generating tumor-reactive T cells is crucial for adoptive cell transfer (ACT) therapy in cancer treatment.
Current methods face challenges in efficiently producing sufficient tumor-specific T cells for therapeutic applications.

Purpose of the Study:

To investigate the use of artificial antigen-presenting cells (aAPCs) for ex vivo activation of tumor antigen-specific T cells.
To optimize aAPC design for enhanced T cell expansion and activation for cancer immunotherapy.

Main Methods:

Utilized lymph nodes from mice bearing sarcomas as a source of tumor antigen-specific T cells.
Developed and tested magnetic beads coated with anti-CD3 and anti-CD28 antibodies as optimal aAPCs.
Performed short-term ex vivo culture of lymph node cells with the optimized aAPCs.

Main Results:

Magnetic bead-based aAPCs effectively activated and expanded tumor antigen-specific CD4+ T cells.
Demonstrated selective expansion and/or activation of desired T cell populations.
Identified bead-coated aAPCs as a promising tool for generating therapeutic T cell cultures.

Conclusions:

Bead-based T cell activation provides a solid foundation for clinical applications in ACT therapy.
This method supports the development of strategies combining in vivo immunization, ex vivo T cell activation, and ACT.
Highlights the potential of engineered aAPCs to advance cancer immunotherapy.

Related Experiment Videos